If you could vote on Brexit now which option would you choose?
   

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine


A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm). Led by Professor Ivan Hung, Chief of Division of Infectious Diseases and Clinical Professor of Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and with the coordination and technical support by HKU Clinical Trials Centre (HKU-CTC), the study aims to evaluate the investigational vaccine's safety and immune response as a booster for adults and will last for around a year. 1,800 adult volunteers who have already received two or three doses of inactivated or mRNA COVID-19 vaccines will be recruited to take part in the study.

News-Medical.Net - June 8, 2022

View the full story here: https://www.news-medical.net/news/20220608/Researchers-plan-to-commence-a-clinical-trial-on-new-COVID-19-inactivated-vaccine.aspx